TRVI Overview
Upcoming Projects (TRVI)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (TRVI)
-
A Fourth View: Examining the potential of Haduvio in prurigo nodularis with a focus on the recent data from the P2b/3 PRISM trial
Tickers: TRVI, REGN, SNY
Executed On: Aug 30, 2022 at 12:00 PM EDT -
A Third View: Examining the potential of Haduvio in prurigo nodularis with a focus on the recent data from the P2b/3 PRISM trial
Tickers: TRVI, REGN, SNY
Executed On: Aug 22, 2022 at 12:00 PM EDT -
A Second View: Examining the potential of Haduvio in prurigo nodularis with a focus on the recent data from the P2b/3 PRISM trial
Tickers: TRVI, SNY, REGN
Executed On: Aug 17, 2022 at 10:00 AM EDT -
Examining the potential of Haduvio in prurigo nodularis with a focus on the recent data from the P2b/3 PRISM trial
Ticker: TRVI
Executed On: Aug 16, 2022 at 01:00 PM EDT
Upcoming & Overdue Catalysts (TRVI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (TRVI)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
